WZH-17-002
WZH-17-002 is an ALKPROTAC degrader based on WZH-15-125, with a DC50 of 25 nM. This compound enhances the efficacy against ALK mutations that confer resistance to Lorlatinib. Moreover, WZH-17-002 significantly reduces resistance in ALK fusion non-small cell lung cancer (NSCLC) and inhibits tumor growth in EML4-ALK G1202R/L1196M xenograft mouse models.
Product Specifications
Field of Research
Cardiovascular Research, Pharmacology & Drug Discovery, Signal Transduction
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR10399030 96 Well
Porcine Suppressor of tumorigenicity 7 protein like (ST7L) ELISA kit
Sign In for Pricing
View Details 
MBS1417310-01 0.02 mg (E-Coli)
Recombinant Rickettsia conorii Putative peptidyl-prolyl cis-trans isomerase RC0542 (RC0542)
Sign In for Pricing
View Details MBS1417310-02 0.02 mg (Yeast)
Recombinant Rickettsia conorii Putative peptidyl-prolyl cis-trans isomerase RC0542 (RC0542)
Sign In for Pricing
View Details MBS1417310-03 0.1 mg (E-Coli)
Recombinant Rickettsia conorii Putative peptidyl-prolyl cis-trans isomerase RC0542 (RC0542)
Sign In for Pricing
View Details MBS1417310-04 0.1 mg (Yeast)
Recombinant Rickettsia conorii Putative peptidyl-prolyl cis-trans isomerase RC0542 (RC0542)
Sign In for Pricing
View Details